TREVI THERAPEUTICS INC
TRVINASDAQ🏆 #1938 by market capEarnings Nov 11US Equity
$13.81▲ $0.29 (+2.14%)
🌙 After hours$13.81▲ 0.00%Regular close · extended-hours price shownTrack TRVI
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d▲ 9.6%
14d▲ 16.2%
30d▼ 3.5%
ytd▲ 10.4%
1y▲ 23.6%
🏦Market Cap
$1.97B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
TREVI THERAPEUTICS INC
TRVIAnalyst Ratings
Price
$13.81
Total
18
Raised
0
Lowered
0
Avg PT
$29.67
H / L
$40 / $23
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Jones Trading | Reiterated | Buy | 2026-08-14 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-08-07 | $25.00 | +81.00% |
Cantor Fitzgerald | Reiterated | Overweight | 2026-08-07 | — | — |
BMO Capital | Reiterated | Outperform | 2026-07-21 | $36.00 | +160.70% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-20 | — | — |
B. Riley Securities | Reiterated | Buy | 2026-07-20 | — | — |
Needham | Reiterated | Buy | 2026-05-20 | — | — |
D. Boral Capital | Reiterated | Buy | 2026-04-17 | — | — |
Morgan Stanley | Reiterated | Overweight | 2026-03-18 | $23.00 | +66.50% |
Stifel | Reiterated | Buy | 2025-12-19 | — | — |
Leerink Partners | Reiterated | Outperform | 2025-11-20 | $16.00 | +15.90% |
Clear Street | Reiterated | Buy | 2025-11-14 | — | — |
Raymond James | Reiterated | Strong Buy | 2025-08-08 | $40.00 | +189.60% |
EF Hutton | Reiterated | Buy | 2024-11-07 | — | — |
JonesTrading | Reiterated | Buy | 2023-03-14 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-11-22 | — | — |
Aegis Capital | Reiterated | Buy | 2022-03-29 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2019-06-03 | $30.00 | +117.20% |
Institution
Jones Trading
Reiterated · Buy · 2026-08-14
—
—
Oppenheimer
Reiterated · Outperform · 2026-08-07
$25.00
+81.00%
Cantor Fitzgerald
Reiterated · Overweight · 2026-08-07
—
—
BMO Capital
Reiterated · Outperform · 2026-07-21
$36.00
+160.70%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-20
—
—
B. Riley Securities
Reiterated · Buy · 2026-07-20
—
—
Needham
Reiterated · Buy · 2026-05-20
—
—
D. Boral Capital
Reiterated · Buy · 2026-04-17
—
—
Morgan Stanley
Reiterated · Overweight · 2026-03-18
$23.00
+66.50%
Stifel
Reiterated · Buy · 2025-12-19
—
—
Leerink Partners
Reiterated · Outperform · 2025-11-20
$16.00
+15.90%
Clear Street
Reiterated · Buy · 2025-11-14
—
—
Raymond James
Reiterated · Strong Buy · 2025-08-08
$40.00
+189.60%
EF Hutton
Reiterated · Buy · 2024-11-07
—
—
JonesTrading
Reiterated · Buy · 2023-03-14
—
—
SVB Leerink
Reiterated · Outperform · 2022-11-22
—
—
Aegis Capital
Reiterated · Buy · 2022-03-29
—
—
Stifel Nicolaus
Reiterated · Buy · 2019-06-03
$30.00
+117.20%
One row per institution · price target from the firm's latest published target